CD34 and acute myeloid leukemia: Next, examining the CD45dim/CD34+ cells (HSPCs), we found an approximate 10-fold reduction in binding compared to lineage cells, and 100-fold lower binding as compared to AML cells (Extended Data Figure 4C).